Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-ND5 pseudogene 20 (MTND5P20) is a pseudogene entry listed by the HUGO Gene Nomenclature Committee (HGNC ID: HGNC:42300)[2]. Pseudogenes are genomic DNA sequences similar to normal genes but are non-functional; they often arise from duplication or retrotransposition events. MTND5P20 does not encode a functional protein and is not known to play any direct role in mitochondrial function, disease, or as a therapeutic target[2][10]. It is distinguished from the functional mitochondrial MT-ND5 gene, which encodes a subunit of complex I of the electron transport chain, by its lack of protein-coding capability and absence of biological activity or pharmacological relevance[1][3][10]. This gene is not considered a receptor, enzyme, transporter, or any therapeutic target. No biological functions, disease associations, relevant interacting drugs, or biomarkers are attributed to MT-ND5 pseudogene 20. The inclusion of "pseudogene" in its name signals that it is not a therapeutically actionable molecule, and queries about its role as a drug target are, therefore, incorrect[2][10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MT-ND5 pseudogene 20 (MTND5P20).